Revolutionizing the probiotic functionality, biochemical activity, antibiotic resistance and specialty genes of Pediococcus acidilactici BCB1H via in-vitro and in-silico approaches
- PMID: 39026396
- DOI: 10.1515/znc-2024-0074
Revolutionizing the probiotic functionality, biochemical activity, antibiotic resistance and specialty genes of Pediococcus acidilactici BCB1H via in-vitro and in-silico approaches
Abstract
This study presents a comprehensive genomic exploration, biochemical characterization, and the identification of antibiotic resistance and specialty genes of Pediococcus acidilactici BCB1H strain. The functional characterization, genetic makeup, biological activities, and other considerable parameters have been investigated in this study with a prime focus on antibiotic resistance and specialty gene profiles. The results of this study revealed the unique susceptibility patterns for antibiotic resistance and specialty genes. BCB1H had good in vitro probiotic properties, which survived well in simulated artificial gastrointestinal fluid, and exhibited acid and bile salt resistance. BCB1H didn't produce hemolysis and had certain antibiotic sensitivity, making it a relatively safe LAB strain. Simultaneously, it had good self-coagulation characteristics and antioxidant activity. The EPS produced by BCB1H also had certain antioxidant activity and hypoglycemic function. Moreover, the genome with a 42.4 % GC content and a size of roughly 1.92 million base pairs was analyzed in the genomic investigations. The genome annotation identified 192 subsystems and 1,895 genes, offering light on the metabolic pathways and functional categories found in BCB1H. The identification of specialty genes linked to the metabolism of carbohydrates, stress response, pathogenicity, and amino acids highlighted the strain's versatility and possible uses. This study establishes the groundwork for future investigations by highlighting the significance of using multiple strains to investigate genetic diversity and experimental validation of predicted genes. The results provide a roadmap for utilizing P. acidilactici BCB1H's genetic traits for industrial and medical applications, opening the door to real-world uses in industries including food technology and medicine.
Keywords: antibiotic resistance; comparative genomics; food technology; metabolic pathways; self-coagulation.
© 2024 the author(s), published by De Gruyter, Berlin/Boston.
References
-
- Qiao, Y, Qiu, Z, Tian, F, Yu, L, Zhao, J, Zhang, H, et al.. Pediococcus acidilactici strains improve constipation symptoms and regulate intestinal flora in mice. Front Cell Infect Microbiol 2021;11:655258. https://doi.org/10.3389/fcimb.2021.655258 . - DOI
-
- Fugaban, JII, Vazquez Bucheli, JE, Park, YJ, Suh, DH, Jung, ES, Franco, BDGD. M, et al.. Antimicrobial properties of Pediococcus acidilactici and Pediococcus pentosaceus isolated from silage. J Appl Microbiol 2022;132:311–30. https://doi.org/10.1111/jam.15205 . - DOI
-
- Song, Y-R, Lee, C-M, Lee, S-H, Baik, S-H. Evaluation of probiotic properties of Pediococcus acidilactici M76 producing functional exopolysaccharides and its lactic acid fermentation of black raspberry extract. Microorganisms 2021;9:1364. https://doi.org/10.3390/microorganisms9071364 . - DOI
-
- Yoon, J-W, Kang, S-S. In vitro antibiofilm and anti-inflammatory properties of bacteriocins produced by Pediococcus acidilactici against Enterococcus faecalis. Foodborne Pathog Dis 2020;17:764–71. https://doi.org/10.1089/fpd.2020.2804 . - DOI
-
- Qiu, Z, Fang, C, Gao, Q, Bao, J. A short-chain dehydrogenase plays a key role in cellulosic D-lactic acid fermentability of Pediococcus acidilactici. Bioresour Technol 2020;297:122473. https://doi.org/10.1016/j.biortech.2019.122473 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous